Burcon Nutrascience Corporation
BRCNF
$1.66
-$0.086-4.91%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.02% | 101.09% | 79.40% | -20.92% | 51.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.02% | 101.09% | 79.40% | -20.92% | 51.51% |
| Cost of Revenue | 1,202.13% | -- | -- | -- | -- |
| Gross Profit | -1,175.26% | -547.02% | -268.27% | -127.24% | -24.22% |
| SG&A Expenses | -15.10% | 1.17% | 15.04% | 12.68% | 2.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.50% | 8.83% | 9.80% | 10.37% | -2.20% |
| Operating Income | -16.71% | -6.39% | -7.94% | -11.96% | 4.24% |
| Income Before Tax | -29.70% | -7.60% | -9.68% | 61.50% | 68.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.70% | -7.60% | -10.55% | 61.40% | 68.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.70% | -7.60% | -10.55% | 61.40% | 68.36% |
| EBIT | -16.71% | -6.39% | -7.94% | -11.96% | 4.24% |
| EBITDA | -16.99% | -6.10% | -7.78% | -12.42% | 4.21% |
| EPS Basic | 9.19% | 15.11% | 6.38% | 67.92% | 72.89% |
| Normalized Basic EPS | 9.21% | 15.12% | -159.29% | 23.78% | 42.60% |
| EPS Diluted | 9.19% | 15.11% | 6.38% | 67.92% | 72.89% |
| Normalized Diluted EPS | 9.21% | 15.12% | -159.29% | 23.78% | 42.60% |
| Average Basic Shares Outstanding | 44.09% | 28.84% | 18.16% | 16.93% | 15.71% |
| Average Diluted Shares Outstanding | 44.09% | 28.84% | 18.16% | 16.93% | 15.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |